Myotonic dystrophy: time for evidence-based therapy

Cardiac involvement in myotonic dystrophy: a nationwide cohort study

(2014) Marie Lund et al.   EUROPEAN HEART JOURNAL

RNA toxicity in human disease and animal models: From the uncovering of a new mechanism to the development of promising therapies

(2013) Géraldine Sicot et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Alternative splicing alterations of Ca2+handling genes are associated with Ca2+signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes

(2013) Massimo Santoro et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Electrophysiological Study With Prophylactic Pacing and Survival in Adults With Myotonic Dystrophy and Conduction System Disease

(2012) Karim Wahbi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The myotonic dystrophies: molecular, clinical, and therapeutic challenges

(2012) Bjarne Udd et al.   LANCET NEUROLOGY

Predictors of Atrio-Ventricular Conduction Disease, Long-Term Outcomes in Patients with Myotonic Dystrophy Types I and II

(2012) ANDREW H. HA et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Cardiac manifestations of myotonic dystrophy type 1

(2011) Helle Petri et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Pacemaker and Implantable Cardioverter-Defibrillator Use in a US Myotonic Dystrophy Type 1 Population

(2011) DEEPAK BHAKTA et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy

(2011) Frédérique Rau et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2

(2010) Anna Vihola et al.   ACTA NEUROPATHOLOGICA